Sustainability Leadership Medichem's certification as a B Corp and its recent launch of Board 2030 highlight its strong commitment to sustainability, social justice, and ethical business practices, making it an attractive partner for clients prioritizing responsible sourcing and corporate social responsibility.

Global Expansion With over 600 clients across more than 60 countries and operations in the USA, Malta, and China, Medichem demonstrates robust international reach and a diversified customer base, offering sales opportunities in multiple key markets.

Product Portfolio & Specialization As a recognized leader in Chlorhexidine-based products with a diversified portfolio of 45 APIs and 20 FDFs, Medichem is well-positioned to meet the needs of companies seeking high-quality generics and contract manufacturing services, especially in infection control and hygiene segments.

Recent Collaborations Strategic partnerships with Breckenridge Pharmaceutical and Redox Pty Ltd indicate Medichem’s active engagement in expanding its distribution channels and collaborative projects, presenting opportunities for joint ventures and bulk sourcing agreements.

Financial & Market Potential With revenue estimates between $25 million and $50 million and a funding amount of $19 million, Medichem offers growth potential for sales through a focus on expanding its API and FDF offerings, especially to clients looking for reliable, sustainable manufacturing partners.